Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Dec 11, 2008

Chromatography firm Dionex last week said its president and CEO Lukas Braunschweiler has resigned, effective May 31, 2009, to become CEO of Ruag Holding, a Swiss-based aviation, defense, and technology company.
The company will start a search soon for a replacement, it said in a statement.
Braunschweiler joined Dionex in the summer of 2002 replacing Blaine Bowman as president and CEO. Before than he was group vice president and head of the laboratory and packaging divisions at Mettler-Toledo.

Tyrian Diagnostics, formerly called Proteome Systems, last week announced the appointment of Merilyn Sleigh to and the resignation of John Martin from the company’s board.
Sleigh is a member of the Australian government’s task force developing a 10-year strategy for the country’s pharmaceutical industry. She also advises the Australian Commonwealth Scientific and Industrial Research Organisation and the Garvan Institute for Medical Research on commercialization efforts.
She is a non-executive director of nutritional firm Clover; drug-discovery company Mimetica; and the Rural Industries Research and Development Council.
Martin had been a director of the company since 2000, and a non-executive director since 2004 when he left the company as deputy CEO. He is currently managing director of Babcock & Brown, a developer and operator of senior living communities.

Strategic Diagnostics announced this week that CFO Stanley Fronczkowski will step down on April 3, 2009, to pursue other interests.
Fronczkowsik was appointed CFO of SD in January 2007 after 29 years at Keystone Foods in various management positions. SD has initiated a national search for his replacement and engaged head-hunting firm Spencer Stuart to assist in the process.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.